Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of rebeccamycin analog and cisplatin with or without
filgrastim in treating patients who have advanced cancer. Drugs used in chemotherapy use
different ways to stop tumor cells from dividing so they stop growing or die. Combining more
than one drug may kill more tumor cells. Colony-stimulating factors such as filgrastim may
increase the number of immune cells found in bone marrow or peripheral blood and may help a
person's immune system recover from the side effects of chemotherapy.